Search for Clinical Trial Results
Optic Nerve Neoplasms - 25 Studies Found
Status | Study |
Terminated |
Study Name: Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1. Condition: Neurofibromatosis Type 1 Date: 2014-02-26 |
Recruiting |
Study Name: A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Condition:
|
Active, not recruiting |
Study Name: PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) Condition:
|
Active, not recruiting |
Study Name: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma Condition:
|
Terminated |
Study Name: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas Condition:
Interventions: Drug: Sorafenib (Nexavar) Sorafenib (in tablet form) will |
Withdrawn |
Study Name: Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma Condition: Optic Nerve Glioma Date: 2010-12-13 Interventions:
|
Recruiting |
Study Name: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Condition:
|
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition:
|
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition:
|
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition:
|